|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-12-16
|
|
pubmed:abstractText |
Acute rejection is still a significant barrier to long-term survival of the allograft. Current acute rejection diagnostic methods are not specific enough or are invasive. There have been a number of studies that have explored the blood or the biopsy to discover genomic biomarkers of acute rejection; however, none of the studies to date have used both.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1534-6080
|
|
pubmed:author |
pubmed-author:BalshawRobR,
pubmed-author:ChenVirginiaV,
pubmed-author:Cohen FreueGabrielaG,
pubmed-author:DawidI GIG,
pubmed-author:HollanderZsuzsannaZ,
pubmed-author:IgnaszewskiAndrewA,
pubmed-author:KeownPaul APA,
pubmed-author:McManusBruce MBM,
pubmed-author:McMasterRobertR,
pubmed-author:MuiAliceA,
pubmed-author:NCE CECR PROOF Centre of Excellence,
pubmed-author:NgRaymondR,
pubmed-author:Wilson-McManusJanetJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
27
|
|
pubmed:volume |
90
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1388-93
|
|
pubmed:meshHeading |
pubmed-meshheading:21076371-Acute Disease,
pubmed-meshheading:21076371-Adult,
pubmed-meshheading:21076371-Aged,
pubmed-meshheading:21076371-Area Under Curve,
pubmed-meshheading:21076371-Biological Markers,
pubmed-meshheading:21076371-Biopsy,
pubmed-meshheading:21076371-Cardiomyopathies,
pubmed-meshheading:21076371-Female,
pubmed-meshheading:21076371-Heart Transplantation,
pubmed-meshheading:21076371-Humans,
pubmed-meshheading:21076371-Male,
pubmed-meshheading:21076371-Middle Aged,
pubmed-meshheading:21076371-Myocardial Ischemia,
pubmed-meshheading:21076371-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:21076371-RNA, Messenger,
pubmed-meshheading:21076371-Transplantation, Homologous
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Whole blood biomarkers of acute cardiac allograft rejection: double-crossing the biopsy.
|
|
pubmed:affiliation |
NCE CECR PROOF Centre of Excellence, Vancouver, BC, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
